Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Baxter
Cantor Fitzgerald
Harvard Business School
Fish and Richardson
US Army
Teva
Johnson and Johnson
McKesson

Generated: November 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020872

« Back to Dashboard

NDA 020872 describes CHILDREN'S ALLEGRA HIVES, which is a drug marketed by Sanofi Aventis Us and is included in three NDAs. It is available from six suppliers. There are two patents protecting this drug. Additional details are available on the CHILDREN'S ALLEGRA HIVES profile page.

The generic ingredient in CHILDREN'S ALLEGRA HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and thirteen suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
Summary for 020872
Tradename:CHILDREN'S ALLEGRA HIVES
Applicant:Sanofi Aventis Us
Ingredient:fexofenadine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020872
Suppliers and Packaging for NDA: 020872
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALLEGRA ALLERGY fexofenadine hydrochloride TABLET;ORAL 020872 NDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-5619 0615-5619-39 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-5619-39)
ALLEGRA ALLERGY fexofenadine hydrochloride TABLET;ORAL 020872 NDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-5620 0615-5620-39 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-5620-39)

Profile for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength30MG
Approval Date:Jan 24, 2011TE:RLD:Yes

Profile for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength30MG
Approval Date:Jan 24, 2011TE:RLD:Yes

Profile for product number 007

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength60MG
Approval Date:Jan 24, 2011TE:RLD:Yes

Expired US Patents for NDA 020872

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us ALLEGRA ALLERGY fexofenadine hydrochloride TABLET;ORAL 020872-007 Jan 24, 2011 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ALLEGRA HIVES fexofenadine hydrochloride TABLET;ORAL 020872-009 Jan 24, 2011 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ALLEGRA HIVES fexofenadine hydrochloride TABLET;ORAL 020872-008 Jan 24, 2011 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ALLEGRA HIVES fexofenadine hydrochloride TABLET;ORAL 020872-008 Jan 24, 2011 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us CHILDREN'S ALLEGRA ALLERGY fexofenadine hydrochloride TABLET;ORAL 020872-005 Jan 24, 2011 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ALLEGRA HIVES fexofenadine hydrochloride TABLET;ORAL 020872-008 Jan 24, 2011 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us CHILDREN'S ALLEGRA HIVES fexofenadine hydrochloride TABLET;ORAL 020872-006 Jan 24, 2011 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Dow
Moodys
Express Scripts
Teva
Argus Health
Federal Trade Commission
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.